Vanrx PharmaSystems is pleased to announce that it has been awarded a grant from Ottawa-based Precarn Incorporated, which supports the federal government’s innovation strategy to accelerate the commercialization of Canada’s vast R&D output to the marketplace while developing a strong technology entrepreneurial talent pool.

Precarn’s T-GAP program will bolster the efforts of 14 growing Canadian technology companies, of which Vanrx PharmaSystems is one.

As a result, Vanrx will collaborate with Saskatchewan Research Council (Saskatoon, SK) to demonstrate the flexibility and reliability of the Vanrx RAPTOR Aseptic Workcell. The SRC facility will play host to a full RAPTOR installation and deployment, where the system’s advanced sterilizeable robotics for aseptic filling will be tested and validated in a real-world environment leveraged by SRC’s experience in vaccine and biological product development.

 

Official Precarn Release…

About Saskatchewan Research Council:

The Saskatchewan Research Council is Saskatchewan’s leading provider of applied research and development (R&D), and technology commercialization. With more than 340 employees, $41 million in annual revenue and 62 years of R&D experience, the corporation provides services and products to companies around the world.

Posted in News